Carlos Folgado
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Carlos Folgado has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Alex Soriano
Hospital Clínic of Barcelona, Barcelona, Spain
1 shared publication - Cristina Lopez-Ferraz
Department of Intensive Care Medicine, Hospital Universitario y Politecnico la Fe, Avda de Fernando Abril Martorell, n.106, Valencia, 46026, Spain
1 shared publication - Esther Villarreal
Intensive Care Unit, IIS La FE, Hospital Universitario y Politécnico La Fe, Valencia, Spain
1 shared publication - Juan Bonastre
Critical Care Department, Hospital La Fe, Valencia, Spain
1 shared publication - Manuel Palomo
Department of Intensive Care Medicine, Hospital Universitario y Politecnico la Fe, Avda de Fernando Abril Martorell, n.106, Valencia, 46026, Spain
1 shared publication - Maria Dolores Gomez
Department of Microbiology, Hospital Universitario y Politecnico la Fe, Valencia, Spain
1 shared publication
Latest Publications
- Open Access
- 20 October 2014
- Published by Springer Nature in Critical Care
- Vol. 18 (5) , 567
Diagnosing external ventricular drain-related ventriculitis by means of local inflammatory response: soluble triggering receptor expressed on myeloid cells-1
Introduction: External ventricular drainage (EVD)-related ventriculitis is one of the most severe complications associated with the use of EVDs. Establishing an early and certain diagnosis can be difficult in critically ill patients. We performed this prospective study to evaluate the usefulness of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) determination in cerebrospinal fluid (CSF) in the diagnosis of ventriculitis. Methods: A prospective observational study was conducted of 73 consecutive patients with EVD. Samples of CSF for culture, cytobiochemical analysis and sTREM-1 determination were extracted three times a week. Ventriculitis diagnosis required a combination of microbiological, cytobiochemical and clinical criteria. Results: Seventy-three consecutive patients were included. EVD-related ventriculitis was diagnosed in six patients and EVD-colonization in ten patients. Patients without clinical or microbiological findings were considered controls. The median CSF sTREM-1 was 4,320 pg/ml (interquartile range (IQR): 2,987 to 4,886) versus 266 pg/ml (118 to 689); P P = 0.001). Serum biomarkers were not useful to diagnose EVD-related infection. These results were confirmed by a case°Control study with ventriculitis patients (cases) and non-ventriculitis (control subjects) matched by age, comorbidities, severity scales and EVD duration (P = 0.004). Conclusions: CSF sTREM-1 was useful in the diagnosis of ventriculitis, in a similar measure to classical CSF parameters. Furthermore, CSF sTREM-1 could prove the diagnosis in uncertain cases and discriminate between EVD-colonization and infection.
- 20 October 2014
- Published by Springer Nature in Critical Care
- Vol. 18 (5) , 567
Open AccessDiagnosing external ventricular drain-related ventriculitis by means of local inflammatory response: soluble triggering receptor expressed on myeloid cells-1
Introduction: External ventricular drainage (EVD)-related ventriculitis is one of the most severe complications associated with the use of EVDs. Establishing an early and certain diagnosis can be difficult in critically ill patients. We performed this prospective study to evaluate the usefulness of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) determination in cerebrospinal fluid (CSF) in the diagnosis of ventriculitis. Methods: A prospective observational study was conducted of 73 consecutive patients with EVD. Samples of CSF for culture, cytobiochemical analysis and sTREM-1 determination were extracted three times a week. Ventriculitis diagnosis required a combination of microbiological, cytobiochemical and clinical criteria. Results: Seventy-three consecutive patients were included. EVD-related ventriculitis was diagnosed in six patients and EVD-colonization in ten patients. Patients without clinical or microbiological findings were considered controls. The median CSF sTREM-1 was 4,320 pg/ml (interquartile range (IQR): 2,987 to 4,886) versus 266 pg/ml (118 to 689); P P = 0.001). Serum biomarkers were not useful to diagnose EVD-related infection. These results were confirmed by a case°Control study with ventriculitis patients (cases) and non-ventriculitis (control subjects) matched by age, comorbidities, severity scales and EVD duration (P = 0.004). Conclusions: CSF sTREM-1 was useful in the diagnosis of ventriculitis, in a similar measure to classical CSF parameters. Furthermore, CSF sTREM-1 could prove the diagnosis in uncertain cases and discriminate between EVD-colonization and infection.